These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 225025)
1. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection. Rojko JL; Hoover EA; Mathes LE; Krakowka S; Olsen RG Cancer Res; 1979 Sep; 39(9):3789-91. PubMed ID: 225025 [TBL] [Abstract][Full Text] [Related]
2. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection. Rojko JL; Hoover EA; Finn BL; Olsen RG J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886 [TBL] [Abstract][Full Text] [Related]
3. Incidence of localized feline leukemia virus infection in cats. Hayes KA; Rojko JL; Mathes LE Am J Vet Res; 1992 Apr; 53(4):604-7. PubMed ID: 1316726 [TBL] [Abstract][Full Text] [Related]
4. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells. Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714 [TBL] [Abstract][Full Text] [Related]
5. Protection against feline leukemia virus infection by use of an inactivated virus vaccine. Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090 [TBL] [Abstract][Full Text] [Related]
6. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum. Rice JB; Olsen RG J Natl Cancer Inst; 1981 Apr; 66(4):737-43. PubMed ID: 6262553 [TBL] [Abstract][Full Text] [Related]
7. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats. Hoover EA; Olsen RG; Mathes LE; Schaller JP Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a feline leukemia virus vaccine in a controlled natural transmission study. Lafrado LJ J Am Vet Med Assoc; 1994 Mar; 204(6):914-7. PubMed ID: 8188511 [TBL] [Abstract][Full Text] [Related]
10. Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection. Haley PJ; Hoover EA; Quackenbush SL; Gasper PW; Macy DW J Natl Cancer Inst; 1985 Apr; 74(4):821-7. PubMed ID: 2985857 [TBL] [Abstract][Full Text] [Related]
11. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies. Lutz H; Pedersen NC; Theilen GH Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819 [TBL] [Abstract][Full Text] [Related]
12. Effect of continuous oral diethylcarbamazine treatment on lymphocyte counts of feline leukemia virus-infected cats. Kitchen LW; Mather FJ; Cotter SM J Clin Lab Immunol; 1988 Dec; 27(4):179-81. PubMed ID: 2855080 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection. Hines DL; Cutting JA; Dietrich DL; Walsh JA J Am Vet Med Assoc; 1991 Nov; 199(10):1428-30. PubMed ID: 1666097 [TBL] [Abstract][Full Text] [Related]
14. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus. Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886 [TBL] [Abstract][Full Text] [Related]
15. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma. Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436 [TBL] [Abstract][Full Text] [Related]
16. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households. Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563 [TBL] [Abstract][Full Text] [Related]
17. Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats. Tandon R; Cattori V; Pepin AC; Riond B; Meli ML; McDonald M; Doherr MG; Lutz H; Hofmann-Lehmann R Virus Res; 2008 Jul; 135(1):136-43. PubMed ID: 18407367 [TBL] [Abstract][Full Text] [Related]
18. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine. Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101 [TBL] [Abstract][Full Text] [Related]
19. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70. Snyder HW; Singhal MC; Hardy WD; Jones FR J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496 [TBL] [Abstract][Full Text] [Related]
20. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets. Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]